                                                  5
        Abstract
        Drugs     intermediates   3,4-dimethoxy-6-nitrobenzoic     acid  synthesis method,
   comprises     the   following    steps:  the  reaction    vessel   was   added   3   mol
 5 2-bromo-3,4-dimethoxy-6-aminoacetophenone solution and 6-8 mol 1,5-pentanediol,
   controlled the stirring speed at 210-250 rpm, kept for 30-40 min, added 600 ml
   potassium carbonate solution, adjusted the pH to 8-9, increased the solution
   temperature to 60-70'C, added 3-5 mol nickel trioxide, continued to react for 30-40
   min, added hydrogen sulfate potassium solution, adjusted the pH to 2-3, reduced the
10 solution temperature to 10-15 C, washed with sodium sulfate solution, washed with
   methyl cyclohexanone        solution, washed    with   1-methyl    naphthalene  solution,
   recrystallizated   in 2-methyl-3-pentanol    solution,   dehydrated with dehydration,
   obtained the product 3,4 - dimethoxy-6-nitrobenzoic acid.

                                                    1
           Drugs intermediates 3,4-dimethoxy-6-nitrobenzoic acid synthesis method
        FIELD OF THE INVENTION
        The        present      invention       relates     to      drugs      intermediates
 5 3,4-dimethoxy-6-nitrobenzoic acid synthesis method.
        GENERAL BACKGROUND
        3,4-dimethoxy-6-nitrobenzoic acid is used as a pharmaceutical intermediate,
   mainly for the synthesis of prazosin and other drugs. However, most of the existing
10 synthetic methods are using lutealdehyde as the reactant, it is complicated and the final
   yield is not very high. Therefore, it is necessary to propose a new synthetic method for
   further improving the quality and yield of the product and reducing the byproduct
   content, it has important economic significance.
15      SUMMARY
        The purpose of the present invention is to provide drugs intermediates
   3,4-dimethoxy-6-nitrobenzoic acid synthesis method, comprises the following steps:
        (i)       The        reaction        vessel       was       added        3      mol
   2-bromo-3,4-dimethoxy-6-aminoacetophenone solution and 6-8 mol 1,5-pentanediol,
20 controlled the stirring speed at 210-250 rpm, kept for 30-40 min, added 600 ml
   potassium carbonate solution, adjusted the pH to 8-9, increased the solution
   temperature to 60-70 'C, added 3-5 mol nickel trioxide, continued to react for 30-40 min,
   added hydrogen sulfate potassium solution, adjusted the pH to 2-3, reduced the solution
   temperature to 10-15 C, washed with sodium sulfate solution, washed with methyl
25 cyclohexanone solution, washed with 1-methyl naphthalene solution, recrystallizated
   in 2-methyl-3-pentanol solution, dehydrated with dehydration, obtained the product
   3,4 - dimethoxy-6-nitrobenzoic acid; wherein, the mass fraction of the potassium
   carbonate solution in step (i) is 10-17%, the mass fraction of the potassium carbonate
   solution in step (i) is 10-17%, the mass fraction of the potassium bisulfate solution in
30 the step (i) is 20-26%, the mass fraction of the sodium sulfate solution in step (i) is

                                                  2
   30-35%, the mass fraction of the methylcyclohexanone solution described in step (i) is
   75-82%, the mass fraction of the 1-methylnaphthalene solution described in step (i) is
   80-86%, the mass fraction of the 2-methyl-3-pentanol solution described in step (i) is
   90-97%.
 5       Throughout the reaction process can be the following reaction formula:
                                                                               OH
                O       CH s
         H2 N      ~        Br                                      2N
                1                 +   C5HJ2O 2 + Ni 20 3   -       02
                                                                                  OCH 3
                   Y        0G~OHg                                         C
                                                                          OCH3
                   OCHs
         Advantage of the present invention is that: reducing intermediate links reaction,
   decreasing the reaction time and improving the reaction yield.
10       DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
         The following examples with reference to specific embodiments of the present
   invention are further illustrated:
         drugs intermediates 3,4-dimethoxy-6-nitrobenzoic acid synthesis method.
15       Embodiment 1
         The         reaction          vessel        was          added       3         mol
   2-bromo-3,4-dimethoxy-6-aminoacetophenone           solution and 6 mol 1,5-pentanediol,
   controlled the stirring speed at 210 rpm, kept for 30 min, added 600 ml potassium
   carbonate solution with a mass fraction of 10%, adjusted the pH to 8, increased the
20 solution temperature to 60 C, added 3mol nickel trioxide, continued to react for 30 min,
   added hydrogen sulfate potassium solution with a mass fraction of 20%, adjusted the
   pH to 2, reduced the solution temperature to 10 0C, washed with sodium sulfate solution
   with a mass fraction of 30%, washed with methyl cyclohexanone solution with a mass
   fraction of 75%, washed with 1-methyl naphthalene solution with a mass fraction of
25 80%, recrystallizated in 2-methyl-3-pentanol solution with a mass fraction of 90%;

                                                 3
   dehydrated with anhydrous potassium carbonate dehydration, obtained the product 3,4
   -dimethoxy - 6 - nitrobenzoic acid 606.09g, yield of 89%.
         Embodiment 2
 5       The        reaction         vessel        was          added         3          mol
   2-bromo-3,4-dimethoxy-6-aminoacetophenone        solution and 7 mol 1,5-pentanediol,
   controlled the stirring speed at 230 rpm, kept for 35 min, added 600 ml potassium
   carbonate solution with a mass fraction of 13%, adjusted the pH to 8.5, increased the
   solution temperature to 65 0C, added 4mol nickel trioxide, continued to react for 35 min,
10 added hydrogen sulfate potassium solution with a mass fraction of 23%, adjusted the
   pH to 2.5, reduced the solution temperature to 12"C, washed with sodium sulfate
   solution with a mass fraction of 32%, washed with methyl cyclohexanone solution
   with a mass fraction of 79%, washed with 1-methyl naphthalene solution with a mass
   fraction of 83%, recrystallizated in 2-methyl-3-pentanol solution with a mass fraction
15 of 93%; dehydrated with anhydrous magnesium sulfate dehydration, obtained the
   product 3,4 -dimethoxy - 6 - nitrobenzoic acid 626.52g, yield of 92%.
         Embodiment 3
         The        reaction         vessel        was          added         3          mol
20 2-bromo-3,4-dimethoxy-6-aminoacetophenone        solution and 8 mol 1,5-pentanediol,
   controlled the stirring speed at 250 rpm, kept for 40 min, added 600 ml potassium
   carbonate solution with a mass fraction of 17%, adjusted the pH to 9, increased the
   solution temperature to 70 C, added 5mol nickel trioxide, continued to react for 40 min,
   added hydrogen sulfate potassium solution with a mass fraction of 26%, adjusted the
25 pH to 3, reduced the solution temperature to 15 C, washed with sodium sulfate solution
   with a mass fraction of 35%, washed with methyl cyclohexanone solution with a mass
   fraction of 82%, washed with 1-methyl naphthalene solution with a mass fraction of
   86%, recrystallizated in 2-methyl-3-pentanol solution with a mass fraction of       9 7 %;
   dehydrated with anhydrous calcium sulfate dehydration, obtained the product 3,4
30 -dimethoxy - 6 - nitrobenzoic acid 653.76g, yield of 96%.

                                                  4
        Claims
         1. Drugs intermediates 3,4-dimethoxy-6-nitrobenzoic acid synthesis method,
   comprises the following steps:
        (i)       the        reaction      vessel       was        added       3       mol
 5 2-bromo-3,4-dimethoxy-6-aminoacetophenone solution and 6-8 mol 1,5-pentanediol,
   controlled the stirring speed at 210-250 rpm, kept for 30-40 min, added 600 ml
   potassium carbonate solution, adjusted the pH to 8-9, increased the solution
   temperature to 60-70'C, added 3-5 mol nickel trioxide, continued to react for 30-40
   min, added hydrogen sulfate potassium solution, adjusted the pH to 2-3, reduced the
10 solution temperature to 10-15 C, washed with sodium sulfate solution, washed with
   methyl cyclohexanone        solution, washed    with   1-methyl   naphthalene  solution,
   recrystallizated   in 2-methyl-3-pentanol    solution,   dehydrated with dehydration,
   obtained the product 3,4 - dimethoxy-6-nitrobenzoic acid; wherein, the mass fraction
   of the potassium carbonate solution in step (i) is 10-17%, the mass fraction of the
15 potassium carbonate solution in step (i) is 10-17%, the mass fraction of the potassium
   bisulfate solution in the step (i) is 20-26%, the mass fraction of the sodium sulfate
   solution in step (i) is 30-35%, the mass fraction of the methylcyclohexanone solution
   described in step (i) is 75-82%.
20      2. Drugs intermediates 3,4-dimethoxy-6-nitrobenzoic         acid synthesis method
   according to claim 1 wherein the mass fraction of the 1-methylnaphthalene solution
   described in step (i) is 80-86%.
        3. Drugs intermediates 3,4-dimethoxy-6-nitrobenzoic         acid synthesis method
25 according to claim 1 wherein the mass fraction of the 2-methyl-3-pentanol solution
   described in step (i) is 90-97%.

